⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10340141 | 1.00 | ALDH1A1 (0.36) | — | |
| SCHEMBL6524 | 1.00 | — | — | |
| SCHEMBL721796 | 1.00 | — | — | |
| SCHEMBL7359 | 0.95 | — | — | |
| SCHEMBL7914 | 0.80 | — | — | |
| SCHEMBL6740 | 0.80 | — | — | |
| SCHEMBL300448 | 0.75 | — | — | |
| SCHEMBL11028224 | 0.70 | — | — | |
| SCHEMBL7631481 | 0.67 | — | — | |
| SCHEMBL1660438 | 0.64 | ALDH1A1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5489 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118344363-A | Tricyclic fused ring derivatives and uses thereof | 广东东阳光药业股份有限公司 | 2024-07-16 | — | — | CN | claimed |
| WO-2024083220-A1 | LIGAND-OLIGONUCLEOTIDE CONJUGATE AND LINKER FOR CONJUGATE | 上海京新生物医药有限公司 | 2024-04-25 | — | — | WO | claimed |
| CN-117794923-A | Benzodioxane compound, and preparation method and application thereof | 南京红云生物科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| US-20240082271-A1 | Methods of Treatment of Fibrotic Diseases | RD NEPHROLOGIE (FR) | 2024-03-14 | — | — | US | claimed |
| WO-2024002379-A1 | COMPOUND USED AS WDR5 INHIBITOR OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE OF COMPOUND | 甘李药业股份有限公司 | 2024-01-04 | — | — | WO | claimed |
| WO-2023222866-A1 | DOSE AND REGIMEN FOR A HETEROCYCLIC PHOSPHINIC COMPOUND | PHOST'IN THERAPEUTICS (FR) | 2023-11-23 | — | — | WO | claimed |
| EP-4277633-A1 | CYCLIC OXAPHOSPHINANE COMPOUNDS AND ANALOGUES THEREOF FOR TREATING FIBROTIC DISEASES | Phost'in Therapeutics (FR) | 2023-11-22 | — | — | EP | claimed |
| US-20230310428-A1 | EGFR INHIBITOR AND PREPARATION METHOD AND USE THEREOF | Hongyun Biotech Co., Ltd. (CN) | 2023-10-05 | — | — | US | claimed |
| CN-113773263-B | 4-amine substituted phthalazinone aurora kinase B inhibitor and preparation and application thereof | 兰州大学 | 2023-09-19 | — | — | CN | claimed |
| CN-116685310-A | Cyclic oxaphosphacyclohexane compounds and analogs thereof for the treatment of fibrotic diseases | 弗斯汀治疗公司 | 2023-09-01 | — | — | CN | claimed |
| EP-0332022-A2 | Magnetic protein conjugates, process for their production and their use | BEHRINGWERKE Aktiengesellschaft (DE) | 1989-09-13 | — | — | EP | claimed |
| CN-88100378-A | New peptidase inhibitors | — | 1988-10-05 | — | — | CN | claimed |
| EP-0275101-A2 | Novel peptidase inhibitors | MERRELL DOW PHARMACEUTICALS INC. (US) | 1988-07-20 | — | — | EP | claimed |
| US-4749687-A | Renin inhibitors containing statine or derivatives thereof | PFIZER INC. (US) | 1988-06-07 | — | — | US | claimed |
| EP-0099336-B1 | 1:2 COBALT COMPLEXES OF AZO DYESTUFFS | CIBA-GEIGY AG (CH) | 1986-04-16 | — | — | EP | claimed |
| EP-0155809-A2 | Renin inhibitors containing statine or derivatives thereof | PFIZER INC. (US) | 1985-09-25 | — | — | EP | claimed |
| EP-0099336-A2 | 1:2 Cobalt complexes of azo dyestuffs | CIBA-GEIGY AG (CH) | 1984-01-25 | — | — | EP | claimed |
| US-4426389-A | BACTERICIDES, ENZYME INHIBITORS | BEECHAM GROUP LIMITED (GB) | 1984-01-17 | — | — | US | claimed |
| US-4264495-A | EXHIBITING GOOD COLOFASTNESS AND DYEABILITY ON POLYAMIDES AND OTHER FIBERS | EASTMAN KODAK COMPANY (US) | 1981-04-28 | — | — | US | claimed |
| US-4052379-A | DYES FROM TRIFLUOROMETHYL-2-AMINOBENZOTHIAZOLE DIAZO COMPONENTS | EASTMAN KODAK COMPANY (US) | 1977-10-04 | — | — | US | claimed |